Results 11 to 20 of about 29,583 (248)

Breast DCE-MRI morphological features and semi-quantitative parameters associated with upgrade to invasive carcinoma in biopsyproven DCIS [PDF]

Radiology and Oncology
The aim of this study was to identify imaging predictors of upgrade to invasive carcinoma (IC) in patients with biopsy-proven ductal carcinoma in situ (DCIS) based on morphological features and semi-quantitative parameters derived from dynamic contrast ...
Urban Vladimir, Milosevic Zorica, Bukumiric Zoran, Obradovic Katarina, Adzic Nina, Pavlovic-Stankovic Dragana, Petkovic Ivana, Sovic Ivana, Jovanic Irena, Spurnic Igor   +9 more
doaj   +2 more sources

Is palpable DCIS more aggressive than screen-detected DCIS?

Surgery Open Science, 2023
Palpable ductal carcinoma in-situ (pDCIS) is a subset of DCIS presenting with a clinical mass. We hypothesized pDCIS would have more aggressive clinical and pathological features, and higher rates of recurrence and upgrade to invasive disease compared to screen-detected DCIS.We performed a retrospective analysis of female patients (age 28-76) with DCIS
Nina Balac, Robert M. Tungate, Young Ju Jeong, Heather MacDonald, Lily Tung, Naomi R. Schechter, Linda Larsen, Stephen F. Sener, Julie E. Lang, Kirstyn E. Brownson   +9 more
openaire   +4 more sources

Clinicopathological features, recurrence patterns, and survival outcomes of triple-negative ductal carcinoma in situ: a single-center cohort study [PDF]

World Journal of Surgical Oncology
Background Triple-negative ductal carcinoma in situ (TN-DCIS) is uncommon, and its prognostic significance remains unclear. We aimed to characterize the clinicopathological features of TN-DCIS and evaluate its association with recurrence outcomes ...
Jingwei Liu, Nan Zhang, Xiujie Yu, Rui Feng, Hong Liu   +4 more
doaj   +2 more sources

DCIS knowledge of women choosing between active surveillance and surgery for low-risk DCIS [PDF]

Breast
Background: Ductal carcinoma in situ (DCIS) can progress to invasive breast cancer (IBC), but often never will. As we cannot predict accurately which DCIS-lesions will or will not progress to IBC, almost all women with DCIS undergo breast-conserving ...
E.G. Engelhardt, R.S.J.M. Schmitz, M.A. Gerritsma, C.M.T. Sondermeijer, E. Verschuur, J.H.E. Houtzager, R. Griffioen, N. Bijker, R.M. Mann, V. Retèl, F.H. van Duijnhoven, J. Wesseling, E.M.A. Bleiker, Alastair Thompson, Serena Nik-Zainal, Elinor J. Sawyer, Helen Davies, Andrew Futreal, Nicholas Navin, E. Shelley Hwang, Jos Jonkers, Jacco van Rheenen, Fariba Behbod, Esther H. Lips, Marjanka Schmidt, Lodewyk F.A. Wessels, Daniel Rea, Proteeti Bhattacharjee, Hilary Stobart, Deborah Collyar, Donna Pinto, Marja van Oirsouw, S. Alaeikhanehshir, L. Elshof   +33 more
doaj   +7 more sources

Integrated Multi-Omics Reveals Cellular States and Microenvironmental Remodeling in Coexisting DCIS and IDC. [PDF]

Adv Sci (Weinh)
Coexisting DCIS and IDC samples are profiled using spatial transcriptomics, single‐cell RNA sequencing, and single‐cell DNA sequencing. Integrative multi‐omics analysis reveals distinct malignant epithelial and microenvironmental features between DCIS and IDC, which are further validated using Xenium and multiplex immunohistochemistry.
Zhang N, Wan T, Zhang S, Jiang Y, Su P, Liu J, Chen Z, Hao J, Wang H, Chen B, Zhao W, Wang L, Xing T, Zhang Q, Schmitz U, Ding Z, Crosetto N, Liu B, Yang Q.   +18 more
europepmc   +2 more sources

Ductal Carcinoma In Situ (DCIS) and Microinvasive DCIS: Role of Surgery in Early Diagnosis of Breast Cancer [PDF]

, 2023
Advances in treatments, screening, and awareness have led to continually decreasing breast cancer-related mortality rates in the past decades. This achievement is coupled with early breast cancer diagnosis.
Veronesi P., Abruzzese G., Galimberti V., Bianchi B., Sacchini V., Corso G., Magnoni F., Di Silvestre S., Alloggio E. A.   +8 more
core   +2 more sources

A New Deep Hybrid Boosted and Ensemble Learning-Based Brain Tumor Analysis Using MRI

Sensors, 2022
Brain tumor analysis is essential to the timely diagnosis and effective treatment of patients. Tumor analysis is challenging because of tumor morphology factors like size, location, texture, and heteromorphic appearance in medical images. In this regard,
Mirza Mumtaz Zahoor, Shahzad Ahmad Qureshi, Sameena Bibi, Saddam Hussain Khan, Asifullah Khan, Usman Ghafoor, Muhammad Raheel Bhutta   +6 more
doaj   +1 more source

Mucocele like Tumour of the Breast Associated with Ductal Carcinoma in situ and Focal Ductal Carcinoma: What is the Best Approach to these Patients? [PDF]

Journal of Clinical and Diagnostic Research, 2016
Mucocele Like Tumours (MLT) of the breast are quite rare neoplasms displaying a broad spectrum. These lesions were considered benign initially. But now, they are believed to be related to atypical ductal hyperplasia, ductal carcinoma, or mucinous ...
Serdar Altinay, Safak Ersöz, Yavuz Üye, Feyyaz Özdemir   +3 more
doaj   +1 more source

Association of clinico-pathological and immunohistochemical prognostic parameters with presence of ductal carcinoma in-situ in an invasive ductal carcinoma of breast

Journal of Pathology of Nepal, 2023
Background: The clinical outcome of breast carcinoma varies in each individual due to its molecular heterogeneity. There is a rising interest in whether the associated ductal carcinoma in-situ in invasive ductal carcinoma of breast affects the prognosis ...
Dhivya Balaiya, Anitha Chellam Annadurai, Jayakarthiga Subbiah Rajasekaran   +2 more
doaj   +1 more source

A multi-phase deep CNN based mitosis detection framework for breast cancer histopathological images

Scientific Reports, 2021
The mitotic activity index is a key prognostic measure in tumour grading. Microscopy based detection of mitotic nuclei is a significant overhead and necessitates automation.
Anabia Sohail, Asifullah Khan, Noorul Wahab, Aneela Zameer, Saranjam Khan   +4 more
doaj   +1 more source